QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文 BMC Medicine, 2022, 卷号: 20, 期号: 1 作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun 收藏  |  浏览/下载：119/0  |  提交时间：2022/11/21 Tucidinostat  Tumor microenvironment  PD-L1  CCL5  Solid tumor   Image classification of immune checkpoint inhibitor-related pneumonia in lung cancer patients 期刊论文 CLINICAL IMAGING, 2022, 卷号: 86 作者:  Sun, Xiaojun;  Song, Zhengbo;  Jiang, Hongyang;  Ma, Yanqing;  Chen, Ming 收藏  |  浏览/下载：8/0  |  提交时间：2022/12/23 Immune checkpoint inhibitor (ICI)  Immune-related adverse events   Immune checkpoint inhibitor-related & nbsp  Lung cancer  Image classification  pneumonia (ICIP)    Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文 BMC PULMONARY MEDICINE, 2022, 卷号: 22 作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan 收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23 Non-small cell lung cancer  Prognosis  Angiogenesis  Tyrosine kinase inhibitors   Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文 GENES CHROMOSOMES & CANCER, 2022 作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping 收藏  |  浏览/下载：29/0  |  提交时间：2022/05/16 BRAF mutation  immune checkpoint inhibitors  non-small cell lung cancer  PD-L1  targeted therapy   Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 期刊论文 TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 页码: 23 作者:  He, Bing-Xi;  Zhong, Yi-Fan;  Zhu, Yong-Bei;  Deng, Jia-Jun;  Fang, Meng-Jie 收藏  |  浏览/下载：29/0  |  提交时间：2022/06/10 Tumor biomarkers  immunotherapy  lung neoplasms  programmed cell death 1 receptor (PD-1 receptor)  biostatistics   Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review 期刊论文 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Lin, Yuxin;  Zhu, Wei;  Wu, Bingchen;  Lan, Huiyin 收藏  |  浏览/下载：18/0  |  提交时间：2022/05/16 Sarcoid-like reaction  immune checkpoint inhibitor  Toripalimab  PD-1  case report   Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China 期刊论文 THORACIC CANCER, 2021 作者:  Shi, Yuequan;  Fang, Jian;  Zhou, Chengzhi;  Liu, Anwen;  Wang, Yan 收藏  |  浏览/下载：61/0  |  提交时间：2022/01/25 advanced lung cancer  immune checkpoint inhibitors  immune-related adverse events  real-world data   A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors 期刊论文 TRANSLATIONAL LUNG CANCER RESEARCH, 2021 作者:  Xu, Xiaoling;  Wang, Ding;  Chen, Wei;  Li, Na;  Suwinski, Rafal 收藏  |  浏览/下载：38/0  |  提交时间：2022/02/14 Immune checkpoint inhibitor (ICI)  non-small cell lung cancer (NSCLC)  peripheral blood lymphocyte subsets   The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study 期刊论文 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021 作者:  Wang, Wenxian;  Gu, Xiaodong;  Wang, Liping;  Pu, Xingxiang;  Feng, Huijing 收藏  |  浏览/下载：26/0  |  提交时间：2022/01/10 Non-small cell lung cancer  PD-L1  Immune checkpoint inhibitor  Immune-related adverse event   Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer 期刊论文 FRONTIERS IN ONCOLOGY, 2020, 卷号: 10 作者:  Wang, Wenxian;  Huang, Zhangzhou;  Yu, Zongyang;  Zhuang, Wu;  Zheng, Weijun 收藏  |  浏览/下载：31/0  |  提交时间：2020/11/30 immune checkpoint inhibitor  non-small cell lung cancer  biomarker  chemotherapy  lung immune prognostic index